Clinical Trial Update: Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update compares palonosetron with ondansetron plus dexamethasone and fosaprepitant for preventing acute and delayed chemotherapy-induced nau…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aloxi (palonosetron hydrochloride)
• Decadron (Dexamethasone)
• Emend IV (fosaprepitant)
• Zofran (Ondansetron)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Breast Neoplasm, Antineoplastic Agents | Phase 2, Phase 3 | Status: UNKNOWN